BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24022692)

  • 41. Differential localization of effector and memory CD8 T cell subsets in lymphoid organs during acute viral infection.
    Jung YW; Rutishauser RL; Joshi NS; Haberman AM; Kaech SM
    J Immunol; 2010 Nov; 185(9):5315-25. PubMed ID: 20921525
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loss of T cell receptor-induced Bmi-1 in the KLRG1(+) senescent CD8(+) T lymphocyte.
    Heffner M; Fearon DT
    Proc Natl Acad Sci U S A; 2007 Aug; 104(33):13414-9. PubMed ID: 17686974
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-intensity exercise elicits the mobilization of senescent T lymphocytes into the peripheral blood compartment in human subjects.
    Simpson RJ; Florida-James GD; Cosgrove C; Whyte GP; Macrae S; Pircher H; Guy K
    J Appl Physiol (1985); 2007 Jul; 103(1):396-401. PubMed ID: 17379755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Id2 influences differentiation of killer cell lectin-like receptor G1(hi) short-lived CD8+ effector T cells.
    Knell J; Best JA; Lind NA; Yang E; D'Cruz LM; Goldrath AW
    J Immunol; 2013 Feb; 190(4):1501-9. PubMed ID: 23325888
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Longitudinal Analysis of the Phenotype, Transcriptional Profile, and Anatomic Location of Memory CD8 T Cell Subsets after Acute Viral Infection.
    Gill AL; Hudson WH; Valanparambil RM; Ahn E; McGuire DJ; Wieland A; McManus DT; Kissick HT; Akondy RS; Ahmed R
    J Virol; 2023 Jan; 97(1):e0155622. PubMed ID: 36541799
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic lymphocytic leukemia specific T-cell subset alterations are clone-size dependent and not present in monoclonal B lymphocytosis.
    te Raa GD; Tonino SH; Remmerswaal EB; van Houte AJ; Koene HR; van Oers MH; Kater AP
    Leuk Lymphoma; 2012 Nov; 53(11):2321-5. PubMed ID: 22646856
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phenotype, function, and gene expression profiles of programmed death-1(hi) CD8 T cells in healthy human adults.
    Duraiswamy J; Ibegbu CC; Masopust D; Miller JD; Araki K; Doho GH; Tata P; Gupta S; Zilliox MJ; Nakaya HI; Pulendran B; Haining WN; Freeman GJ; Ahmed R
    J Immunol; 2011 Apr; 186(7):4200-12. PubMed ID: 21383243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells.
    Coscia M; Vitale C; Peola S; Foglietta M; Rigoni M; Griggio V; Castella B; Angelini D; Chiaretti S; Riganti C; Guarini A; Drandi D; Ladetto M; Bosia A; Foà R; Battistini L; Boccadoro M; Fournié JJ; Massaia M
    Blood; 2012 Oct; 120(16):3271-9. PubMed ID: 22932792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential in vivo persistence of two subsets of memory phenotype CD8 T cells defined by CD44 and CD122 expression levels.
    Walzer T; Arpin C; Beloeil L; Marvel J
    J Immunol; 2002 Mar; 168(6):2704-11. PubMed ID: 11884436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structure of natural killer cell receptor KLRG1 bound to E-cadherin reveals basis for MHC-independent missing self recognition.
    Li Y; Hofmann M; Wang Q; Teng L; Chlewicki LK; Pircher H; Mariuzza RA
    Immunity; 2009 Jul; 31(1):35-46. PubMed ID: 19604491
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Senescence marker killer cell lectin-like receptor G1 (KLRG1) contributes to TNF-α production by interaction with its soluble E-cadherin ligand in chronically inflamed joints.
    Melis L; Van Praet L; Pircher H; Venken K; Elewaut D
    Ann Rheum Dis; 2014 Jun; 73(6):1223-31. PubMed ID: 23740233
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The NK receptor KLRG1 is dispensable for virus-induced NK and CD8+ T-cell differentiation and function in vivo.
    Gründemann C; Schwartzkopff S; Koschella M; Schweier O; Peters C; Voehringer D; Pircher H
    Eur J Immunol; 2010 May; 40(5):1303-14. PubMed ID: 20201037
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early KLRG1
    Hoji A; Popescu ID; Pipeling MR; Shah PD; Winters SA; McDyer JF
    J Immunol; 2019 Oct; 203(8):2063-2075. PubMed ID: 31554693
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased KLRG1 and PD-1 expression on CD8 T lymphocytes in TB-IRIS.
    Goovaerts O; Massinga-Loembé M; Ondoa P; Ceulemans A; Worodria W; Mayanja-Kizza H; Colebunders R; Kestens L;
    PLoS One; 2019; 14(4):e0215991. PubMed ID: 31022273
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo.
    Kalia V; Sarkar S; Subramaniam S; Haining WN; Smith KA; Ahmed R
    Immunity; 2010 Jan; 32(1):91-103. PubMed ID: 20096608
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IL-12 signaling drives CD8+ T cell IFN-gamma production and differentiation of KLRG1+ effector subpopulations during Toxoplasma gondii Infection.
    Wilson DC; Matthews S; Yap GS
    J Immunol; 2008 May; 180(9):5935-45. PubMed ID: 18424713
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distinctive patterns of naïve/memory subset distribution and cytokine expression in CD4 T lymphocytes in ZAP-70 B-chronic lymphocytic patients.
    Monserrat J; Sánchez MÁ; de Paz R; Díaz D; Mur S; Reyes E; Prieto A; de la Hera A; Martínez-A C; Alvarez-Mon M
    Cytometry B Clin Cytom; 2014 Jan; 86(1):32-43. PubMed ID: 24166938
    [TBL] [Abstract][Full Text] [Related]  

  • 58. EOMES is essential for antitumor activity of CD8
    Llaó-Cid L; Roessner PM; Chapaprieta V; Öztürk S; Roider T; Bordas M; Izcue A; Colomer D; Dietrich S; Stilgenbauer S; Hanna B; Martín-Subero JI; Seiffert M
    Leukemia; 2021 Nov; 35(11):3152-3162. PubMed ID: 33731848
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunophenotypic and DNA genotypic analysis of T-cell and NK-cell subpopulations in patients with B-cell chronic lymphocytic leukaemia (B-CLL).
    Frolova EA; Richards SJ; Jones RA; Rawstron A; Master PS; Teasdale J; Short M; Jack AS; Scott CS
    Leuk Lymphoma; 1995 Jan; 16(3-4):307-18. PubMed ID: 7719238
    [TBL] [Abstract][Full Text] [Related]  

  • 60. T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers.
    Palma M; Gentilcore G; Heimersson K; Mozaffari F; Näsman-Glaser B; Young E; Rosenquist R; Hansson L; Österborg A; Mellstedt H
    Haematologica; 2017 Mar; 102(3):562-572. PubMed ID: 27927767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.